Get the Stockscreener App
10.63
0.19%
-0.02
Translational Development Acquisition Corp stock is traded at $10.63, with a volume of 3,780.
It is down -0.19% in the last 24 hours and up +0.47% over the past month.
Translational Development Acquisition Corp is a newly organized blank check company.
See More
Previous Close:
$10.65
Open:
$10.63
24h Volume:
3,780
Relative Volume:
0.22
Market Cap:
$232.88M
Revenue:
-
Net Income/Loss:
$6.36M
P/E Ratio:
36.60
EPS:
0.2904
Net Cash Flow:
$-608.40K
1W Performance:
-0.56%
1M Performance:
+0.47%
6M Performance:
+1.72%
1Y Performance:
+4.73%
1-Day Range:
$10.63
$10.63
1-Week Range:
$10.63
$10.65
52-Week Range:
$10.15
$10.69
Translational Development Acquisition Corp Stock (TDAC) Company Profile
Name
Translational Development Acquisition Corp
Sector
Industry
Phone
(413) 204-2769
Address
52 E 83RD ST., NEW YORK
Compare TDAC vs LION, XXI, UMAC, DMII, BCSS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDAC
Translational Development Acquisition Corp
|
10.63 | 233.31M | 0 | 6.36M | -608.40K | 0.2904 |
LION
Lionsgate Studios Corp
|
12.20 | 3.55B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.83 | 2.76B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
13.74 | 692.44M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.01 | 637.64M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.16 | 593.93M | 0 | 0 | 0 | 0.0729 |
Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-21-21 | Initiated | Northland Capital | Outperform |
Translational Development Acquisition Corp Stock (TDAC) Latest News
IMG Pharmaceutical Co Ltd To Acquire Matsumoto Pharmaceutical Co Ltd To Strengthen Integrated Healthcare Platform - BioPharma APAC
TDACW Translational releases no quarterly earnings data as it continues its search for viable SPAC merger targets.Social Trade Signals - Xã Thanh Hà
GSK Completes Acquisition of 35Pharma for $950 Million - Voice of Healthcare
Published on: 2026-04-14 00:50:36 - baoquankhu1.vn
TDAC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Portfolio Update: Can Maywood Acquisition Corp Debt Equity Composite Units deliver consistent dividends2026 Market Trends & Accurate Intraday Trading Signals - baoquankhu1.vn
Tavia Acquisition (NASDAQ:TAVI) Trading 0.1% Higher – Here’s What Happened - Defense World
Translational Development Acquisition (NASDAQ:TDACU) Trading Up 3% – Here’s What Happened - Defense World
Growth Report: Can NTRP expand into new markets2026 Summary & Expert-Curated Trade Recommendations - baoquankhu1.vn
VION Biosciences Closes Acquisition of CTL, Strengthening Functional Immune Monitoring Capabilities - Business Wire
Is Translational (TDAC) Stock Testing Resistance | Price at $10.59, Up 0.09%Loss Prevention - UBND thành phố Hải Phòng
DYOR PE Ratio & Valuation, Is DYOR Overvalued - Intellectia AI
Spartacus Acquisition Corp. II Warrants (TMTSW) stock price, news, quote and history - Yahoo Finance Singapore
Opendoor Technologies Inc. (OPENW) stock price, news, quote and history - Yahoo Finance UK
symbol__ Stock Quote Price and Forecast - CNN
TDAC (NASDAQ: TDAC) details 2025 SPAC results, trust balance and June 2026 deadline - Stock Titan
Translational Development Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy - NTB Kommunikasjon
Translational Development Acquisition Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Stock List: Research Stocks from Around the World - GuruFocus
Tavia Acquisition Corp. (TAVI) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Rally Mode: Is Ainos Inc a play on infrastructure spendingWeekly Risk Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
Market Review: Can Translational Development Acquisition Corp outperform in the next rallyChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Okogen Acquires Ranpirnase Assets and Intellectual Property Portfolio - StreetInsider
TDAC Should I Buy - Intellectia AI
Geopolitics Watch: Is Tapestry Inc a defensive stock2026 Historical Comparison & Daily Chart Pattern Signals - baoquankhu1.vn
Profit Recap: Is Qiagen NV part of any major indexShare Buyback & Stepwise Trade Execution Plans - baoquankhu1.vn
NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026 - Business Wire
Gains Recap: Is Translational Development Acquisition Corp undervalued by DCF analysisPortfolio Return Summary & Reliable Price Action Trade Plans - baoquankhu1.vn
TDAC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Aug Update: Is Newbury Street II Acquisition Corp affected by consumer sentimentMarket Growth Summary & AI Powered Market Trend Analysis - baoquankhu1.vn
Harvard Bioscience 2026 Investor Overview: Translational Science Tools, Growth Strategy, and Financial Outlook - Minichart
Buy Signal: Can HUSA generate free cash flow2026 Levels & Weekly High Potential Stock Alerts - baoquankhu1.vn
Retail Trends: Will NCMI benefit from AI trends2026 WrapUp & Community Trade Idea Sharing - baoquankhu1.vn
Aug Macro: Is Translational Development Acquisition Corp attractive at current valuation2026 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn
Buy Signal: How liquid is TBCPW stock2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn
Volatility Watch: Is AEye Inc stock risky to hold nowTrade Exit Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Latest Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk
Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk
IPO Launch: Should you avoid TPST stock right nowAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn
Stock Recap: Is LCII a speculative investmentMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Movement Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsPortfolio Update Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Stock Analysis: Will CIMG Inc announce a stock split2025 Short Interest & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Published on: 2026-02-21 02:25:17 - mfd.ru
Published on: 2026-02-21 08:39:55 - baoquankhu1.vn
Volume Report: Is CICXU currently under institutional pressureEarnings Overview Summary & Accurate Buy Signal Alerts - baoquankhu1.vn
Axol Bioscience makes third acquisition in five years - Business Weekly
Axol Bioscience acquires ophthalmology business from Newcells Biotech - Cambridge Network
Can Translational Development Acquisition Corp. Equity Warrant stock double in next 5 yearsEntry Point & Daily Profit Maximizing Trade Tips - mfd.ru
Why Critical Metals Corp. stock could outperform in 2025Quarterly Market Review & Technical Entry and Exit Alerts - mfd.ru
Why NOVA stock remains resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru
Translational Development Acquisition Corp Stock (TDAC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.49%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):